CSI Market
Sign In | Register

Bohai Pharmaceuticals Group (BOPH) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access BOPH quarterly Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Bohai Pharmaceuticals Group adapts its cash strategy across cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Jun 30 2014)
12 Months 		(Jun 30 2013) (Jun 30 2011) (Jun 30 2013)
Operating Activities
Income21.89
Depreciation & amortization5.52
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-1.71
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-0.20
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Accretion Of Beneficial Conversion Feature-
Allowance For Loan And Lease Losses Recoveries Of Bad Debts-
Indefinite Lived Intangible Assets Impairment Losses-
Other Receivable And Prepayments-
Income taxes0.92
Unrealized Gain (Loss) on Derivatives0.00
Increase (Decrease) in Accounts Receivable-2.78
Increase (Decrease) in Accounts Payable1.10
Increase (Decrease) in Accrued Liabilities-0.33
Increase (Decrease) in Customer Advances0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.36
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.24
Discontinued operations0.00
Net Cash flow from Operating Activities25.01
Investing Activities
Capital Expenditures-6.09
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Purchase Of Leased L and Use Rights-
Purchase Of Formulas-
Property Plant And Equipment Deposits-
Payments to Acquire Restricted Certificates of Deposit0.00
Payments for (Proceeds from) Loans0.00
Proceeds from Other Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross-5.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-11.09
Financing Activities
Short-term debt Net14.65
Other borrowing transactions0.00
Long-term debt - borrowings0.24
Long-term debt - repayments-10.61
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-5.12
Deposit Of Restricted Cash Note Payable4.88
Deposit Of Restricted Cashconvertible Note Escrow Deposit-
Release Of Restricted Cashconvertible Note Escrow Deposit-
Deposit Of Restricted Cash Convertible Note Escrow Deposit0.14
Release Of Restricted Cash Convertible Note Escrow Deposit-0.14
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities4.04
Effect of exchange rate on cash flow-1.60
Discontinued operations0.00
Free Cash Flow18.92
Total Cash Flow16.36
4 historic quarters locked

Sign in to unlock the full Bohai Pharmaceuticals Group cash flow history.

Sign In Create Free Account

About BOPH Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License